Back to search

University of Ioannina

Μεταγωγή του σήματος από ακτιβίνη Α στα ενδοθηλιακά κύτταρα: διερεύνηση των μηχανισμών και διασύνδεση με την ενδοκυτταρική μεταφορά μεμβρανών

Abstract

dc:description

TGFβ superfamily is comprised of a large number of growth factors, which play an important role in a variety of cellular functions. The common SMAD4 (co-SMAD), oligomerizes with receptor phosphorylated SMAD proteins (R-SMADs), and therefore constitutes an important component of the signal transduction of all members of this superfamily, and indeed is essential for propagation of the signal. In this thesis, in collaboration with Philippe Chavrier, SMAD4 was found to interact with ARF6 in a yeast-two-hybrid screen. This interaction was confirmed biochemically with pull-down and co- immunoprecipitation experiments. We expressed three forms of ARF6 (wild type WT, constitutively active Q67L mutant and GDP-bound inactive mutant T27N) and found that only the constitutively active form of ARF6 interacts with SMAD4. Moreover, we have shown that the ARF6Q67L-SMAD4 interaction is specific for ARF6: it was not observed with the constitutively active forms of ARF1 (ARF1Q71L) or ARF5 (ARF5Q71L), representatives of class I and II, of ARF GTPases, respectively. Subsequently, we addressed whether ARF6 interacts with the R-SMADS, SMAD2/SMAD3. Indeed, pull down experiments confirmed that ARF6Q67L associates with both SMAD2 and SMAD3. Further, co-immunoprecipitation experiments of ARF6Q67L, with either SMAD2, 3 or 4, showed that in the absence of TGFβ, SMAD2,3, and 4 proteins co-immunoprecipitated with ARF6Q67L, while in the presence of TGFβ, only SMAD3 co-immunoprecipitated. The above results were confirmed with the use of constitutively activated SMAD2 (EDME) and SMAD3 (EDVE), constructed by mimicking the receptor phosphorylation sites on both proteins. Indeed, ARF6Q67L co-immunoprecipitated SMAD3 (EDVE), while SMAD2 (EDME) was only marginally co-immunoprecipitated. In conclusion, SMAD4 and unphosphorylated SMAD2 and 3 (in the absence of ligand) are associated with ARF6Q67L, while in the presence of ligand, only SMAD3-P associates with ARF6Q67L. Domain mapping experiments of SMAD2, 3, and 4 mediating the association with ARF6Q67L were carried out. The SMAD4 domain responsible for the association with constitutively active ARF6Q67L is contained within the last 32-carboxy-terminal amino acids. In agreement, deletion of this domain in full length SMAD4 disrupted the interaction with ARF6Q67L. Furthermore, co-immunoprecipitation experiments of ARF6Q67L with SMAD2 and SMAD3 deletion constructs demonstrated that ARF6Q67L is associated with the last 40-carboxyterminal amino acids of SMAD2, as in the case of SMAD4, while the interaction domain of SMAD3 lies upstream. Due to the fact that ARF6Q67L physically associated with SMAD2 and SMAD3 in the absence of ligand, it was imperative to check the possibility that this association decreases, due to competitive binding, the availability of SMAD2 and SMAD3 proteins for phosphorylation from the ligand activated type I receptors. Thus, we investigated the effect of overexpressed ARF6 (WT, Q67L and T27N) on SMAD2 and SMAD3 phosphorylation induced by TGFβ and Activin A. In the presence of TGFβ, in FIUVE endothelial cells, as well as in embryonic renal 293 cells, we found that all forms of ARF6 dramatically reduced SMAD2 phosphorylation levels by approximately 80%. In the case of SMAD3, all forms of ARF6 reduced SMAD3 phosphorylation levels by approximately 40% following TGFβ. On the contrary, ARF6 did not influence the phosphorylation of SMAD2/SMAD3 induced by Activin A in FIUVE and 293 cells. The lack of ARF6 reduction of SMAD2 and SMAD3 phosphorylation upon Activin A addition indicates that the association of ARF6 with these SMADs does not influence their availability, due to competitive binding, for phosphorylation from activated type I receptor. In parallel, two other conclusions were drawn from previous experiments. First, the inhibition of SMAD2/3 phosphorylation (after TGFβ treatment) by ARF6wt, ARF6Q67L and ARF6T27N, could be attributed to the inhibition of TGFβ receptor endocytosis, a process which is considered essential so that SMAD2/3 are activated at the level of the early endocytic compartment. This specific activity of ARF6 is influenced by the cycle of its GTP-GDP exchange so that both constitutively active and constitutively inactive form of ARF6 have inhibitory action towards receptor endocytosis/recycling. The same has been reported to happen with the overexpressed ARF6wt as well, however the mechanism has not been clarified. Indeed, overexpression of ARNO protein (GEF of ARF6), which activates ARF6 without “locking” ARF6 in the GTP form, did not have any negative effect on SMAD2/3 phosphorylation upon TGFβ treatment. Second, the fact that SMAD2/3 phosphorylation upon Activin A is not influenced by ARF6wt, ARF6Q67L and ARF6T27N leads to the conclusion that either Activin A receptors are endocytosed via ARF6-independent processes, or that Activin A does not need endocytosis to phosphorylate SMAD2/3 proteins. A number of transcriptional regulation experiments led to the conclusion that the physical association of ARF6 and SMAD proteins, and its effect on phosphorylation through the inhibition of receptor phosphorylation, result in the inhibition of SMAD2 and SMAD3 transcriptional activity. Finally, we show that not only does the ARF6 activation status influence TGFβ superfamily signal transduction, but TGFβ also influences the level of ARF6 activation. In fact, our experimental data showed that within 20 min TGFβ converts ARF6 to the inactive form (GDP bound). Therefore, it appears that due to the ARF6-GTP inhibitory action on SMAD-dependent transcription, TGFβ maximizes its signal transduction by shifting ARF6 to its inactive GDP form. Therefore, our experimental data raise the possibility for further studies including detailed investigation of bidirectional interaction between ARF6 and TGFβ/Activin A, where the one system influences the functionality of the other.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chira, Panagiota
  • Χήρα, Παναγιώτα

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17442

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chira, Panagiota; Χήρα, Παναγιώτα. Μεταγωγή του σήματος από ακτιβίνη Α στα ενδοθηλιακά κύτταρα: διερεύνηση των μηχανισμών και διασύνδεση με την ενδοκυτταρική μεταφορά μεμβρανών. University of Ioannina, 2009. http://hdl.handle.net/10442/hedi/17442